These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23407165)

  • 81. The enhancement of glycolysis regulates pancreatic cancer metastasis.
    Yang J; Ren B; Yang G; Wang H; Chen G; You L; Zhang T; Zhao Y
    Cell Mol Life Sci; 2020 Jan; 77(2):305-321. PubMed ID: 31432232
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.
    Binker MG; Binker-Cosen MJ; Binker-Cosen AA; Cosen-Binker LI
    JOP; 2014 Jul; 15(4):280-5. PubMed ID: 25076320
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.
    Brandi J; Dando I; Pozza ED; Biondani G; Jenkins R; Elliott V; Park K; Fanelli G; Zolla L; Costello E; Scarpa A; Cecconi D; Palmieri M
    J Proteomics; 2017 Jan; 150():310-322. PubMed ID: 27746256
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
    Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
    Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism.
    Wellen KE; Lu C; Mancuso A; Lemons JM; Ryczko M; Dennis JW; Rabinowitz JD; Coller HA; Thompson CB
    Genes Dev; 2010 Dec; 24(24):2784-99. PubMed ID: 21106670
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hypoxia and pancreatic ductal adenocarcinoma.
    Yamasaki A; Yanai K; Onishi H
    Cancer Lett; 2020 Aug; 484():9-15. PubMed ID: 32380129
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia.
    Fan J; Kamphorst JJ; Mathew R; Chung MK; White E; Shlomi T; Rabinowitz JD
    Mol Syst Biol; 2013 Dec; 9():712. PubMed ID: 24301801
    [TBL] [Abstract][Full Text] [Related]  

  • 88. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming.
    Anand S; Khan MA; Zubair H; Sudan SK; Vikramdeo KS; Deshmukh SK; Azim S; Srivastava SK; Singh S; Singh AP
    EMBO Rep; 2023 Mar; 24(3):e55643. PubMed ID: 36592158
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer.
    Maurer HC; Garcia-Curiel A; Holmstrom SR; Castillo C; Palermo CF; Sastra SA; Andren A; Zhang L; Le Large TYS; Sagalovskiy I; Ross DR; Wong W; Shaw K; Genkinger J; Manji GA; Iuga AC; Schmid RM; Johnson K; Badgley MA; Lyssiotis CA; Shah Y; Califano A; Olive KP
    bioRxiv; 2024 Jun; ():. PubMed ID: 36993718
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer.
    Liu C; Deng S; Xiao Z; Lu R; Cheng H; Feng J; Shen X; Ni Q; Wu W; Yu X; Luo G
    Discov Oncol; 2023 Feb; 14(1):20. PubMed ID: 36797531
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cancer metabolism and mass spectrometry-based proteomics.
    Zhou W; Liotta LA; Petricoin EF
    Cancer Lett; 2015 Jan; 356(2 Pt A):176-83. PubMed ID: 24262660
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment.
    Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139512
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Rapid uptake of glucose and lactate, and not hypoxia, induces apoptosis in three-dimensional tumor tissue culture.
    Kasinskas RW; Venkatasubramanian R; Forbes NS
    Integr Biol (Camb); 2014 Apr; 6(4):399-410. PubMed ID: 24503640
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lactate as a signaling molecule: Journey from dead end product of glycolysis to tumor survival.
    Rawat D; Chhonker SK; Naik RA; Mehrotra A; Trigun SK; Koiri RK
    Front Biosci (Landmark Ed); 2019 Jan; 24(2):366-381. PubMed ID: 30468661
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hypoxia induced tumor metabolic switch contributes to pancreatic cancer aggressiveness.
    Vasseur S; Tomasini R; Tournaire R; Iovanna JL
    Cancers (Basel); 2010 Dec; 2(4):2138-52. PubMed ID: 24281221
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Novel Translational Activation of HIF1α Promotes Pancreatic Cancer Growth Through Glycolytic Reprogramming.
    Zhang Y; Houchen CW; Li M
    Gastroenterology; 2022 Apr; 162(4):1040-1042. PubMed ID: 35120914
    [No Abstract]   [Full Text] [Related]  

  • 97. Suppression of fatty acid oxidation supports pancreatic cancer growth and survival under hypoxic conditions through autophagy induction.
    Kim B; Gwak J; Kim M; Yang S; Hwang S; Shin S; Kim JH; Son J; Jeong SM
    Cancer Gene Ther; 2023 Jun; 30(6):878-889. PubMed ID: 36807391
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival.
    Singh L; Nair L; Kumar D; Arora MK; Bajaj S; Gadewar M; Mishra SS; Rath SK; Dubey AK; Kaithwas G; Choudhary M; Singh M
    Front Oncol; 2023; 13():1034205. PubMed ID: 36761981
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Glycolytic Enzymes Coalesce in G Bodies under Hypoxic Stress.
    Jin M; Fuller GG; Han T; Yao Y; Alessi AF; Freeberg MA; Roach NP; Moresco JJ; Karnovsky A; Baba M; Yates JR; Gitler AD; Inoki K; Klionsky DJ; Kim JK
    Cell Rep; 2017 Jul; 20(4):895-908. PubMed ID: 28746874
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets.
    Słotwiński R; Lech G; Słotwińska SM
    Cent Eur J Immunol; 2021; 46(2):258-263. PubMed ID: 34764796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.